A quinoxaline 1,4-di-N-oxide derivative induces DNA oxidative damage not attenuated by vitamin C and E treatment

被引:37
作者
Azqueta, Amaia
Arbillaga, Leire
Pachon, Gisela
Cascante, Marta
Creppy, Edmond E.
Lopez de Cerain, Adela
机构
[1] Univ Navarra, CIFA, Pamplona 31008, Spain
[2] Univ Barcelona, Fac Chem, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain
[3] Univ Bordeaux 2, Dept Toxicol & Appl Hyg, F-33076 Bordeaux, France
关键词
bioreductive agent; comet assay; Caco-2; cells; DNA oxidative damage; vitamin C; vitamin E; quinoxalines;
D O I
10.1016/j.cbi.2007.02.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Some anticancer compounds are pro-drugs which give rise to toxic species through enzymatic reduction. The quinoxalinedi-N-oxide derivative Q-85 HCl (7-chloro-3-[[(NN-dimethylamino)propyl]amino]-2-quinoxalinecarbonitrile 1,4-di-N-oxide hydrochloride) is a bioreductive compound selectively toxic in hypoxia. Due to the possibility of secondary tumors the study of the genotoxic capability of antitumoral drugs is very important. The aim of this study was to assess the ability of Q-85 HCl to produce reactive oxygen species (ROS) and oxidative DNA damage in Caco-2 cells, both in hypoxia and in well-oxygenated conditions. Secondly, we attempted to evaluate the effect of vitamins C and E under hypoxic and normoxic conditions, in order to determine if these antioxidant substances modify Q-85 HCl effect in hypoxic cells or possibly exert a protective action in normal cells. Caco-2 cells were treated with Q-85 HCl for 2 h, at high concentrations in normoxia (0.1-5 mu M) and at low concentrations in hypoxia (0.002-0.1 mu M). In normoxia, a dose-related significant increase in intracellular ROS level was evident; in hypoxia all the concentrations produced very high level of ROS. Just after the treatment and 24 h later, oxidative DNA damage was evaluated by the modified comet assay after post-digestion of the cells with formamidopyrimidine-DNA glycosylase (FPG) and endonuclease III (Endo 111). Q-85 HCl treatment evoked a significant dose-dependent increase in the total comet score of the cells both in hypoxia and normoxia, indicating that this compound or some metabolite is able to oxidize purine and pyrimidine bases. After 24 h DNA damage caused by the compound was completely repaired with only one exception: cells treated with the highest concentration of Q-85 HCl in hypoxia and post-digested with FPG. Vitamin C (5-100 mu M) and vitamin E (500-400 mu M) did not have a pro-oxidant effect in Caco-2 cells. Treatment of cells with vitamin C (10 mu M) or vitamin E (100 mu M) did not significantly reduce oxidative DNA damage in hypoxia and normoxia. In conclusion, the use of these vitamins would not hinder toxicity against hypoxic cells, but a protective effect in normoxic cells was not evident. 0 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:95 / 105
页数:11
相关论文
共 57 条
[1]  
Azqueta A, 2005, ARZNEIMITTELFORSCH, V55, P177
[2]   DNA damage induced by a quinoxaline 1,4-di-N-oxide derivative (hypoxic selective agent) in Caco-2 cells evaluated by the comet assay [J].
Azqueta, A ;
Pachón, G ;
Cascante, M ;
Creppy, EE ;
de Cerain, AL .
MUTAGENESIS, 2005, 20 (03) :165-171
[3]   SR-4233 CYTOTOXICITY AND METABOLISM IN DNA REPAIR-COMPETENT AND REPAIR-DEFICIENT CELL-CULTURES [J].
BIEDERMANN, KA ;
WANG, J ;
GRAHAM, RP ;
BROWN, JM .
BRITISH JOURNAL OF CANCER, 1991, 63 (03) :358-362
[4]   Quenching of reactive oxidative species by probucol and comparison with other antioxidants [J].
Bisby, RH ;
Johnson, SA ;
Parker, AW .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (03) :411-420
[5]   SUBSTRATE-SPECIFICITY OF THE ESCHERICHIA-COLI FPG PROTEIN (FORMAMIDOPYRIMIDINE DNA GLYCOSYLASE) - EXCISION OF PURINE LESIONS IN DNA PRODUCED BY IONIZING-RADIATION OR PHOTOSENSITIZATION [J].
BOITEUX, S ;
GAJEWSKI, E ;
LAVAL, J ;
DIZDAROGLU, M .
BIOCHEMISTRY, 1992, 31 (01) :106-110
[6]  
Borek Carmia, 2004, Integr Cancer Ther, V3, P333, DOI 10.1177/1534735404270578
[7]  
Brown JM, 1999, CANCER RES, V59, P5863
[8]   Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies [J].
Brown, JM .
MOLECULAR MEDICINE TODAY, 2000, 6 (04) :157-162
[9]   THERAPEUTIC ADVANTAGE OF HYPOXIC CELLS IN TUMORS - A THEORETICAL-STUDY [J].
BROWN, JM ;
KOONG, A .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (03) :178-185
[10]  
Brown JM, 1998, CANCER RES, V58, P1408